Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
14.9M
-
Shares change
-
+400K
-
Total reported value, excl. options
-
$76M
-
Value change
-
+$1.68M
-
Number of buys
-
12
-
Number of sells
-
-25
-
Price
-
$5.10
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q4 2017
54 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q4 2017.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.9M shares
of 386M outstanding shares and own 3.87% of the company stock.
Largest 10 shareholders include Paradice Investment Management LLC (1.64M shares), JANUS HENDERSON GROUP PLC (1.41M shares), HEARTLAND ADVISORS INC (1.35M shares), Russell Investments Group, Ltd. (1.2M shares), Lapides Asset Management, LLC (1.17M shares), Boston Partners (1.07M shares), FIRST WILSHIRE SECURITIES MANAGEMENT INC (1.03M shares), Senvest Management, LLC (1M shares), 22NW, LP (874K shares), and STONEHILL CAPITAL MANAGEMENT LLC (739K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.